Lexeo Therapeutics (LXEO) Times Interest Earned (2022 - 2026)

Lexeo Therapeutics has reported Times Interest Earned for 5 years, with the latest figure at -$8.09 in Q1 2026.

• Quarterly Times Interest Earned rose 87.24% year-over-year to -$8.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35.43 (down 110.69% YoY) and the FY2025 annual result came in at -$0.92, up 94.54% from the prior year.
• Times Interest Earned rose to -$8.09 in Q1 2026 per LXEO's latest filing, from -$11.13 in the prior quarter.
• Over five years, Times Interest Earned peaked at $78.74 in Q4 2022 and troughed at -$299.48 in Q4 2023.
• A 5-year average of -$28.55 and a median of -$5.71 in 2024 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned surged 106.35% in 2024, then plunged 4867.23% in 2025.
• Over 5 years, Times Interest Earned stood at $78.74 in 2022, then plunged by 480.34% to -$299.48 in 2023, then jumped by 106.35% to $19.0 in 2024, then tumbled by 158.57% to -$11.13 in 2025, then rose by 27.3% to -$8.09 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$8.09, -$11.13, and -$2.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.